FDA Week - 11/09/2018

Device And Rare Disease Lobbies Expect Continued Bipartisan Support

November 07, 2018
The Advanced Medical Technology Association (AdvaMed) and the National Organization for Rare Disorders (NORD) are confident that the interests of their constituencies will be well represented despite the shift from a GOP-led to Democrat-led House, plus some changes in the Senate, after the midterm elections. Spokespeople for the groups say they owe their optimism to robust bipartisan backing of several recent bills such as the Orphan Products Extension Now Accelerating Cures and Treatments Act (OPEN ACT) and the Protecting Medical...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.